News

Pharma Cluster Accelerator Announces New Diversity, Equity and Inclusion Lead

New position ensures access to opportunities created by the Advanced Pharmaceutical Research and Manufacturing Cluster regardless of race, ethnicity, gender, or geographic location.

Richmond, VA –  The Cluster Accelerator for Advanced Pharmaceutical Research and Manufacturing, an entity launched to fast-track the development of a globally competitive essential medicines manufacturing hub across Central Virginia, announced the hiring of Vanessa Womack as its lead for Diversity, Equity and Inclusion. The new position will oversee efforts to ensure the diverse rural-urban community that comprises the Greater Richmond-Petersburg MSA can participate in opportunities created by the emerging Advanced Pharmaceutical Research and Manufacturing industry.

Jeff Gallagher, interim Executive Director of the Cluster Accelerator said, “We are excited to have Ms. Womack as part of our team and we will lean on her expertise in diversity, equity and inclusion, to help us craft and execute on a strategy to support these efforts in life sciences. We are building a global industry and we are scaling up quickly, and the selection of Vanessa will ensure the opportunities and benefits of this emerging industry extend to the diverse population in the region.” The Central Virginia region is diverse, covering five cities and twelve counties with both urban and rural populations.

The New Diversity, Equity and Inclusion Lead role will be responsible for driving a region-wide diversity, equity and inclusion strategy, and will coordinate and implement regional efforts to support an inclusive culture for life sciences, focusing initially on the DEI plan component of the Build Back Better Regional Competition grant award from the US Economic Development Administration (EDA). Working collaboratively with public and private sector organizations, Ms. Womack will design and execute the strategy to engage the community training, employment and supplier for life sciences and act as an important community liaison.

Prior to this role, Ms. Womack served as Programs, Training and Technical Assistance Planner at the Virginia Community Healthcare Association for nearly nine years developing strategic training programming and advancing efforts to grow an educational resource for healthcare leaders. She also has significant experience in DEI initiatives through her consulting company, Vanessa Womack Consulting, working with organizations on managing diverse teams, improving organizational culture, and board training.

The Advanced Pharmaceutical Manufacturing and Research & Development (R&D) Cluster Accelerator is built upon regional research, innovation and manufacturing assets with a goal of building a world-class hub to research and manufacture essential medicines for Americans by leveraging our competitive assets.

The regional cluster accelerator’s goal is to help build a globally competitive pharmaceutical manufacturing and R&D industry in the Central Virginia region. The work will fast-track regional efforts to reshore and secure the production of essential medicines in the United States, lower their costs and ensure access to quality medicines in the U.S. and around the world. Many organizations will support scale-up in infrastructure, workforce development, and supply chain development.

Read more here.

Recent News

01/29/2026

NIRSense, Inc. & Aspen Medical USA (AMUSA): Strengthening Frontline Medicine: U.S.–Developed Tissue Oxygenation Technology Delivered to Ukraine

NIRSense and Aspen Medical USA (AMUSA) are pleased to announce the donation of 12 portable tissue-ischemia monitoring kits (comprising advanced sensor consoles plus tablets) to the Ministry of Defence of Ukraine (MoD) for deployment in frontline Role-1 and Role-2 casualty care facilities in Ukraine. These investigational prototype systems are provided for use by military medical

01/28/2026

Call for Judges for Science Fair

Each year, Virginia Bio recruits volunteer judges from the membership to attend the Virginia State Science and Engineering Fair to select the top three winners in the field of biosciences. The time commitment is limited to a pre-event online review of the submissions to select the finalists and then a few hours onsite at the

01/28/2026

University of Virginia Signs Master Research Collaboration Agreement with AstraZeneca to Accelerate Pre-Clinical Innovation

The University of Virginia (UVA) today announced the signing of a Master Research Collaboration Agreement with AstraZeneca designed to expedite pre-clinical research partnerships between the global biopharmaceutical company and UVA’s schools and departments. The agreement streamlines processes and enables AstraZeneca’s research and development teams to work more effectively and efficiently across UVA’s breadth of scientific